Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
61 Cards in this Set
- Front
- Back
Erythrocytes
|
Membrane contains chloride-bicarbonate antiport
- important in physiologic chloride shift, allowing RBCs to transport CO2 from the periphery to the lungs for elimination Chloride shift: many bicarb ions diffuse OUT of RBCs intok plasma; to maintain electrical neutrality, Cl- ions diffuse into RBCs to take their place. 1* cause of high RBC Cl- content in venous blood |
|
Leukocytes
|
Granulocytes = basophils, eosinophils, neutrophils
Mononuclear cells = lymphocytes, monocytes |
|
Basophils
|
Contain heparin, histamine, LTD-4
Found in BLOOD |
|
Mast cell
|
Degranulation --> histamine, heparin, eosinophil chemotactic factors
FOUND IN TISSUE |
|
Caues of eosinophilia
|
NAACP:
Neoplastic Asthma Allergic processes Collagen vascular dz Parasites |
|
Neutrophils
|
40-75% WBCs
Acute inflammatory response cell - PHAGOCYTIC w/ hydrolytic enzymes, lysozymes, lysozymes, myeloperoxidase, lactoferrin Hypersegmented in B12 defic Toxic granulations + Dohle Bodies (dilated ER) - reactive changes of neutrophils indicative of overwhelming infec's like bacterial sepsis |
|
Platelet
|
Dense granules = ADP, Ca2+
Alpha granules = vWF, fibrinogen |
|
Dendritic cells
|
Main inducers of 1* antibody response
If on skin = Langerhans cells Express on surface: MHC II FcR |
|
Vascular endothelial cells
|
Inside endothelial cells:
- vWF - thromboplastin = tissue factor (VII --> VIIa in extrinsic pathway) - tPA - PGI2 & NO --> decrease platelet aggregation On surface of endothelial cells: - thrombomodulin activates ProtC Activated ProtC cleaves & inactivates Va, VIIIa |
|
Platelet adhesion to collagen
|
Subendothelial collagen exposed
vWF binds to collagen Gp1b (on platelet surface) binds to vWF |
|
Platelet-platelet adhesion
|
Binding of ADP on platelet receptors --> insertion of GpIIb/IIIa on platelet membrane --> platelet cohesion
Increased aggregation w/ TXA2 released by platelets |
|
Antithrombin III
|
inactivates factors II, VII, IX, X, XI
|
|
Pure Red Cell Aplasia
|
Rare form of marrow failure
- marked hypoplasia of marrow erythroid cells w/ normal granulopoiesis and thrombopoiesis assoc w/ thymoma or parvoB19 infection |
|
Fibrinolytic system
|
Plasminogen --> Plasmin
* facilitated by kallikrein Fibrin --> Fibrin split products * facilitated by Plasmin |
|
Microcytic, Hypochromic Anemia
|
MCV<80
Fe2+ defic Thalassemias - target cells Lead poisoning |
|
Macrocytic Anemia
|
MCV>100
VitB12/folate defic Drugs that block DNA synth Marked reticulocytosis |
|
Normocytic, Normochromic Anemia
|
Acute hemorrhage
Enzyme defects - G6PD (XR), PK defic (AR) RBC membrane defects BM disorders Hemoglobinopathies Autoimmune hemolytic anemia Anemia of chronic disease |
|
Hepcidin
|
Low Fe --> inc hepcidin synth
Adeq Fe --> dec hepcidin synth |
|
Haptoglobin
& LDH |
Dec Haptoglobin (binds free Hb)
& Inc sr LDH = RBC hemolysis |
|
ACD
|
Inc ferritin
Dec TIBC Inc cytokines (IL-1, IFN-y, TNF) --> Fe sequestered in macrophages, poor utilization for erythropoiesis |
|
Ferritin
|
Measure of storage Fe
Derived from total body pool in liver, spleen, marrow Dec in Fe-defic |
|
Transferrin
|
Transports iron through plasma
Inc synth in Fe-defic |
|
Myelophthisic Anemia
|
Inc. alk phosphatase
Hypercalcemia Leukoerythroblastic pattern All consequences of tumor = space occupying lesion ex. prostatic adenoCA (mets to bone or infection) |
|
Hemoconcentration
|
Dehydration --> Relative polycythemia
Usually you also see hypernatremia |
|
Lead Poisoning
|
Affected enzymes:
1. Ferrochelatase 2. ALA dehydratase Accumulated substrate in urine: 1. Coproporphyrin 2. ALA |
|
Acute intermittent porphyria
|
Affected enzymes:
1. Uroporphyrinogen I synthase Accumulated substrate in urine: 1. Porphobilinogen 2. d-ALA Sx's: Painful abd, pink urine, polyneuropathy, psychological disturbances, precipitated by drugs |
|
Porphyria cutanea tarda
|
Affected enzyme:
1. Uroporphyrinogen decarboxylase Accumulated substrate in urine: 1. Uroporphyrin (tea-colored) |
|
Hb Synthesis
|
Starting substrates:
Succinyl Co-A + Glycine |
|
Hb synth
|
Mitochondria:
1. ALA Synthase + B6 Succinyl coA + Glycine --> dAminolevulinic acid Cytosol: 2. ALA dehydratase dAminolevulinic acid --> Porphobilinogen 3. Porphobilinogen deaminase Porphobilinogen --> Pre-uroporphyrinogen |
|
Hb synth
|
4. Pre-uroporphyrinogen --> Uroporphyrinogen III
5. Uroporphyrinogen decarboxylase Uroporphyrinogen III --> Coproporphyrinogen MITOCHONDRIA: 6. Coproporphyrinogen --> Protoporphyrin |
|
Hb synth
|
Iron (ferritin) --> Trasferrin --> Fe2+
7. Ferrochelatase Protoporphyrin + Fe2 --> Heme 8. Heme + Globin --> Hb |
|
Aplastic Anemia
|
Pancytopenia
Causes: Radiation, Benzene, Chloramphenicol, Alkylating agents, Antimetabolites, Viral agents (B19, EBV, HIV), Fanconi's anemia |
|
HbC
|
Beta-chain mutation
Milder type of sickling than HbSS |
|
Alpha thalassemia
|
Underproduced alpha-globin chain
HbH = beta-4 tetramers; lack 3 alpha-globin genes HbBarts = gamma-4 tetramers; lack 4 alpha-globin genes |
|
Beta-thalassemia
|
Due to mutations in splicing sites and promoter sequences
Inc HbF and HbA2 Requires blood transfusions --> 2* hemochromatosis --> cardiac failure Marrow expansion --> skeletal deformities ("crew cut" skull) |
|
Autoimmune anemia
|
IgG = warm, CHRONIC
- SLE, CLL, drugs - extravascular hemolysis IgM = cold, ACUTE - triggered by cold, M. pneumoniae, mono - erythroblastosis fetalis |
|
Paroxysmal nocturnal hemoglobinuria
|
Intravascular hemolysis from lytic activity of complement
Impaired GPI anchor/decay-accelerating factor in RBC membrane PIGA gene mut |
|
Hereditory spherocytosis
|
Extravascular hemolysis
|
|
Microangiopathic anemia
|
Intravascular hemolysis
DIC TTP/HUS SLE malign HTN Schistocytes |
|
TTP
|
Platelet abnormality
sx's of classic pentad: 1. Neuro problems 2. Fever 3. Thrombocytopenia 4. MAHA 5. Acute renal failure Inher/acq defic of vWF metalloprotein ADAMST13) --> multimers of vWF --> aggreg & organ dysfxn |
|
Defect in Platelet plug formation
|
Inc. BT
1. Glanzmann's thrombasthenia = dec GpIIb/IIIa --> platelet-platelet aggregation defic 2. Bernard Soulier dz = dec Gp1b --> defect in platelet-collagen adhesion 3. vW dz = dec vWF --> defect in platelet-collagen adhesion |
|
Desmopressin
|
Inc vwF release from endothelial cells in 30-60 min
Good in surgery /mild defic to control bleeding ; not good to use in severe def |
|
Hodgkin's Lymphoma
|
RS cells
LOCALIZED SINGLE group of nodes - rare extranodal - CONTIGUOUS spread (stage = strongest px) constitutional sx's mediastinal lymphadenopathy 50% assoc w/ EBV bimodal distrib. |
|
NHL
|
HIV/immunosuppression related
MULTIPLE PERIPHREAL nodoes extranodal invovlemet is common NONCONTIGUOUS spread Majority involve B-cells Fewer constitutional signs/sx's |
|
Sinus histiocytosis
|
Immunologic response to cancer Ag
thus not all enlarged lymph nodes are metastatic |
|
Leukemoid Reaction
|
Marked leukocytosis and immature myeloid cells in peripheral blood --> exag response to infection
DIFFERENTIATE from CLL: alkaline phosphatase Inc = leukemoid Dec = CML (phil chr) Both have inc WBC |
|
MALT lymphoma
|
middle aged adults
at site of autoimmune/infectious stimulus (ex. H pylori or rugal folds) common sites - thyroid (hashimoto's), salivary glands (Sjogrens), stomach (H. pylori) Monoclonal in origin (=malignant) regress w/ antibiotic tx * Can transform to diffuse large B-cell lymphoma |
|
Waldenstrom's macroglobulinemia
|
M spike = IgM
hyperviscosity sx's no lytic bone lesions |
|
MGUS
|
monoclonal gammopathy of undetermined significance
- asymptomatic - M protein spike in absence of any assoc dz of B-cells - no BJ proteinuria - progress to MM in 20% pts |
|
MM
|
IgG or IgA overproduction
Characteristic sx's: 1. Normocytic/chromic anemia 2. IL-6 --> osteoclast activation --> bone resorption (pathologic fractures, soap bubble lytic lesions) - RANKL cytokine --> activates osteoclasts 3. Hypercalcemia 4. Monoclonal Ig 5. AL amyloid - apple green birefring 6. Renal failure |
|
t(9;22)
|
Philadelphia chr
bcr-abl hybrid uncontrolled tyrosine kinase of fusion gene |
|
t(8;14)
|
Burkitt's lymphoma
c-myc activation starry sky appearance EBV assoc |
|
t(14:18)
|
Follicular lymphoma
bcl-2 activation |
|
t(15;17)
|
M3 type of AML
Auer rods - peroxidase(+) cytoplasmic inclusions in granulocytes and myeloblasts greatly inc. circulating myeloblasts on peripheral smear responsive to all-trans retinoic acid |
|
t(11;22)
|
Ewing's sarcoma
|
|
t(11;14)
|
mantle cell lymphoma
|
|
CLL/SLL
|
older adults (>60y)
lymphadenopathy, hepatosplenomegaly indolent course inc smudge cells in peripheral blood smear warm Ab autoimmune hemolytic anemia NO BLAST PHASE |
|
CML
|
bcr-abl phil chr
inc neutrophils, metamyelocytes, basophils, splenomegaly may acclerate to AML or ALL via BLAST CRISIS L-shift with all stages of myeloid maturation on peripheral smear VERY LOW leukocyte alkaline phosphatase (v. leukemoid rxn) Responsive to imatinib (anti bcr-abl) |
|
Hairy cell leukemia
|
TRAP stain (+)
|
|
Langerhans cell histiocytoses
|
Prolif disorder of dendritic cells from monocyte lineage
Defective cells express S100 & CD1a Birbeck granules gen sx's: seborrheic skin eruptions, fever, recurrent otitis media infec's, lymphadenopathy, hepatomegaly, splenomegaly Letterer-Siew dz = lytic skull lesions Hand-Schuller-Christian dz = exophthalmos, diab insipidus Eosinophilic granulomas |
|
Myelodysplasia
|
Cellular marrow w/ maturation defects in MULTIPLE lesions
- jak2 mut's implicated in myeloprof disorders other than CML (polycy vera, essential thrombocytosis, myelofibrosis) Failure of hematop. cells to mature normally --> not released into peripheral blood --> pancytopenia --> susceptible to infections clonal cell disorders can be due to: 1. de novo 2. post tx w/ alkylating agents = 5q deletion |